Avid Bioservices Inc banner

Avid Bioservices Inc
NASDAQ:CDMO

Watchlist Manager
Avid Bioservices Inc Logo
Avid Bioservices Inc
NASDAQ:CDMO
Watchlist
Price: 12.49 USD 0.08%
Market Cap: $801.1m

Avid Bioservices Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Avid Bioservices Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Avid Bioservices Inc
NASDAQ:CDMO
Revenue
$150.4m
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
21%
Abbvie Inc
NYSE:ABBV
Revenue
$59.6B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$29.4B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Amgen Inc
NASDAQ:AMGN
Revenue
$36.8B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
5%
Astria Therapeutics Inc
NASDAQ:ATXS
Revenue
$706k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$12B
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
28%
No Stocks Found

Avid Bioservices Inc
Glance View

Market Cap
801.1m USD
Industry
Biotechnology

Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

CDMO Intrinsic Value
6.27 USD
Overvaluation 50%
Intrinsic Value
Price

See Also

What is Avid Bioservices Inc's Revenue?
Revenue
150.4m USD

Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Revenue amounts to 150.4m USD.

What is Avid Bioservices Inc's Revenue growth rate?
Revenue CAGR 10Y
21%

Over the last year, the Revenue growth was -16%. The average annual Revenue growth rates for Avid Bioservices Inc have been 12% over the past three years , 18% over the past five years , and 21% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett